Nanomedicine: NBM, 2015, 11, 657-670.
D. Bechet, F. Auger, P. Couleaud, et al.
Archives Publications 2015
Ultrasmall nanoplatforms as calcium-responsive contrast agents for magnetic resonance imaging
Small, 2015, 11, 4900-4909.
A. Moussaron, S. Vibhute, A. Bianchi, et al.
Ultrasmall particles for Gd-MRI and 68Ga-PET dual imaging
Contrast Media Mol. Imaging, 2015, 10, 309-319.
C. Truillet, P. Bouziotis, C. Tsoukalas, et al.
Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma
Nanomedicine: NBM, 2015, 11, 247-257.
I. Miladi, M.-T. Aloy, E. Armandy, et al.
Nebulized gadolinium-based nanoparticles : a theranostic approach for lung tumor imaging and radiosensitization
Small, 2015, 11, 215-221.
S. Dufort, A. Bianchi, M. Henry, et al.
Orotracheal administration of contrast agents: a new protocol for brain tumor targeting
NMR Biomed., 2015, 28, 738-746.
A. Bianchi, D. Moncelet, F. Lux, et al.
Gadolinium nanoparticles and contrast agent as radiation sensitizers
Phys. Med. Biol., 2015, 60, 4449-4464.
F. Taupin, M. Flaender, R. Delorme, et al.
Evaluation of a gadolinium-based nanoparticle (AGuIX) for contrast enhanced MRI of the liver in a rat model of hepatic colorectal cancer metastases at 9.4 tesla
Rofo., 2015, 187, 1108-1115.
P. Fries, D. Morr, A. Müller, et al.
Gadolinium based-nanoparticles for theranostic MRI-Radiosensitization
Nanomedicine, 2015, 11, 1801-1815.
F. Lux, L. Sancey, A. Bianchi, et al.
Nanoparticules ultrafines en radiothérapie : le cas des AGuIX
Cancer Radiother., 2015, 19, 508-514.
F. Lux, A. Detappe, S. Dufort, et al.
Long-Term in vivo clearance of Gadolinium-Based AGuIX (Activation and Guiding of Irradiation by X-Ray) Nanoparticles and their Biocompatibility after Systemic Injection
ACS Nano, 2015, 9, 2477-2488.
L. Sancey, S. Kotb, C. Truillet, et al.
AGuIX nanoparticles as a promising platform for image-guided radiation therapy
A.Detappe, S.Kunjachan, J.Rottmann, et al.